IL6 and rheumatoid arthritis: In RA patients, DCs release DA during antigen presentation to naive CD4+ T lymphocytes [245], which raises IL-6-dependent IL-17 production via D1-like receptors, in response to T lymphocyte activation by anti-CD3 and anti-CD28 [244].